SAPC ASM 2022 - UCLan - Talk Abstracts

Back to SAPC ASM 2022 - UCLan

  1. 3E.1
    EMPOWER Exploring & Mapping PriOrities for Women’s health technology, Equipment, kit, devices, and pRoducts
  2. 3E.2
    The Australian Contraception and Abortion Primary Care Practitioner Support (AusCAPPS) Network: A protocol for delivering and evaluating an online community of practice
  3. 3E.3
    The ORIENT trial: protocol for evaluating the effect of a nurse-led model on contraception and medical abortion access in Australian rural & regional general practice
  4. 3E.4
    A systematic review of the effectiveness of preconception interventions in primary care
  5. 3E.5
    Epidemiology and microbiological features associated with greater risk of recurrent urinary tract infection
  6. 3F.1
    More unequal than before? Access to general practice in a time of remote consultations and digital primary care.
  7. 4A.1
    ‘Educational change in a crisis; what has changed and what is here to stay in undergraduate teaching and learning in General Practice.’
  8. 4A.2
    Supporting medical students towards future careers in general practice: a quantitative study of Irish medical schools
  9. 4A.3
    Exploring teacher and learner experiences of the University of Exeter Medical School (UEMS) 2018 undergraduate general practice curriculum
  10. 4A.4
    Can a student-led teaching intervention improve student and staff understanding of LGBTQ+ identities and health-related issues in undergraduate medicine?
  11. 4A.5
    What do medical students learn? What are medical students taught about Persistent Physical Symptoms? A scoping review of the literature
  12. 4A.6
    ‘A drive to make change’ - Exploring the views and experiences of medical students engaging in advocacy: a qualitative study.
  13. 4A.7
    Extended GP placements in final year - why do students choose them?
  14. 4A.8
    Medical student attitudes towards General Practice resulting from UK media portrayal of GP during the COVID-19 pandemic
  15. 4B.1
    Early cancer diagnosis – can outcomes in deprived areas be improved by involving community pharmacists?
  16. 4B.2
    Exploring the impact of significant others on men on the active surveillance pathway for prostate cancer: a qualitative interview dyad study
  17. 4B.3
    ThinkCancer! Feasibility trial - to phase 3 or not phase 3?
  18. 4B.4
    Patient views about early diagnosis and prevention of breast cancer
  19. 4B.5
    Provider perceptions of interventions to encourage prevention and early diagnosis of cancer after a negative diagnosis
  20. 4B.6
    What is the evidence behind cancer care reviews, a British primary care cancer support tool? A scoping review

Pages